Lifestyle Factors and Cancer Survivorship: Observational Findings of Weight, Physical Activity, and Diet on Survival

Size: px
Start display at page:

Download "Lifestyle Factors and Cancer Survivorship: Observational Findings of Weight, Physical Activity, and Diet on Survival"

Transcription

1 Lifestyle Factors and Cancer Survivorship: Observational Findings of Weight, Physical Activity, and Diet on Survival Melinda L. Irwin, PhD, MPH Associate Professor of Epidemiology Yale School of Medicine Yale School of Public Health

2 AICR s 2009 Annual Research Conference on Food, Nutrition, Physical Activity and Cancer November 5-6, 2009 Capital Hilton, Washington, DC No Relevant Financial Relationships No Conflict of Interest

3 Lifestyle Habits and Breast Cancer Survival Despite advances in adjuvant treatment, over 40,000 women still die of breast cancer each year. Current breast cancer therapies do not address the association of obesity and sedentary lifestyle effects on prognosis. Obesity and physical inactivity are common before and after a breast cancer diagnosis.

4 Mortality from Cancer According to BMI for U.S. Women in the Cancer Prevention Study II Calle, E. et al. N Engl J Med 2003;348:

5 Mortality from Cancer According to BMI for U.S. Men in the Cancer Prevention Study II Calle, E. et al. N Engl J Med 2003;348:

6 Meta-analysis Evaluating Measures of Adiposity at Diagnosis and Prognosis Recurrence at 5 yrs Death at 10 yrs HR [95% CI] HR [95% CI] Body Weight 1.78[ ] 1.36[ ] BMI 1.91[ ] 1.60[ ] Goodwin, P.. In: Psychosomatic Obstetrics and Gynecology, Bitzer J. and Stauber M. (Eds); Monduzzi Editore, International Proceedings Division, Bologna (Italy), p , 1995.

7 Weight and Survival in Early-Stage Breast Cancer Estimated Relative Risk of Adverse Event Distant Recurrence, p= Death, p= BMI (kg/m 2 ) Goodwin et al, JCO 2002

8 Post-Diagnosis Weight Gain and Breast Cancer Death in Women with BMI < 25 at diagnosis 2 P trend < HR Breast Cancer Death Maintain Gain < 2.0 kg/m2 Gain > 2.0 kg/m2 Kroenke C JCO 2005

9 In Population Studies, Overweight/Obesity Affects Breast Cancer Prognosis in: Premenopausal patients Postmenopausal patients Patients diagnosed with any disease stage Patients treated with any combination of surgery, radiation, systemic chemotherapy Cheblowski, Aiello, McTiernan JCO 2002;20(4):

10 4 Changes in Exercise Frequency across the Colon Cancer Experience (N = 130) 3 Sessions Per week 2 1 Moderate Strenuous 0 Prediagnosis Active Treatment Post Treatment Courneya K and Friedenreich C. J Altern Complem Med 1997

11 Exercise Patterns across the Colon Cancer Experience (N = 130) % Maintainers Temporary Relapsers Permanent Relapsers Nonexercisers Adopters Courneya K and Friedenreich C. J Altern Complem Med 1997

12 Physical Activity Before and After Diagnosis in Breast Cancer Survivors The HEAL Study P<.05 P<.05 P<.05 Hours/wee Before Diagnosis After Diagnosis In situ Stage I Stage II-IIIa Stage Irwin M. et al. Cancer 2003;97:

13 Physical Activity across the Breast Cancer Experience by BMI (HEAL Study, N = 547) 4 3 Hrs/week Year Before Diagnosis Within 1st Year Post- Diagnosis Within 3rd Year Post- Diagnosis Irwin ML et al MSSE 2004 BMI < 25 BMI: BMI > 30

14 Weight Change from Baseline to 2 yrs by change in PA (N = 544) kg kg * < 90 min/wk min/wk 150+ min/wk Irwin ML et al. JCO, 2005

15 Benefits of Increasing Post-Diagnosis PA Need to encourage cancer survivors to maintain (if active prior to diagnosis) or increase PA after diagnosis. PA is associated with numerous benefits Decreasing adverse side effects of surgery and treatment Improving quality of life and fatigue Improving fitness, functional capacity, and body composition Decreasing serum hormones and growth factors Improving cancer-specific survival and all cause survival

16 Physical Activity and Increased Survival in Breast Cancer Survivors More than four observational studies have examined the relationship between post-diagnosis physical activity and mortality after breast cancer diagnosis % reduced risk with 2-3 hr/wk of moderate-intensity exercise Associations stronger in women with higher disease stage Holmes M et al JAMA 2005; Holick C et al. CEBP 2008; Pierce J et al JCO 2007; Irwin ML et al JCO, 2008.

17 Nurses Health Study: Physical activity after breast cancer diagnosis HR P =.05 P=.004 P =.003 Recurrence BRCA Death Total Death MET-hr/wk MET-Hrs/week < Holmes *p=0.05, M et al JAMA # p<

18 Multivariable-Adjusted Relative Risk of Breast Cancer Death According to 2 Physical Activity Categories After Breast Cancer Diagnosis* Holmes, M. D. et al. JAMA 2005;293:

19 The HEAL Study: Physical Activity after Diagnosis Hazard Ratio for Death P =.46 BC Death P =.04 Total Death MET-hr/wk 0 > Irwin ML et al JCO, 2008.

20 Women s Health Initiative (WHI) WHI enrolled healthy postmenopausal women and collected physical activity information at least every 3 years. ~5430 women developed breast cancer while enrolled in WHI. Pre- and Post-diagnosis PA and other lifestyle and prognostic information were collected prospectively. Irwin, Chlebowski, McTiernan et al.

21 Post-diagnosis Physical Activity and Colorectal Cancer Survival: NHS Findings Meyerhardt, J. A. et al. J Clin Oncol; 24:

22 NHS and Change in Physical Activity Meyerhardt, J. A. et al. J Clin Oncol; 24:

23 The Women s Interventional Nutrition Study (WINS) Randomized 2400 women with early-stage breast cancer to low-fat diet intervention or control group Intervention involved oneon-one meetings with dietician, cooking classes WINS diet: reduce fat to 15% of total calories Chlebowski et al. JNCI, 2006.

24 Results by hormonal subtype ER Negative ER Positive Chlebowski, JNCI 2006

25 The Women s Healthy Eating and Living Study (WHEL) Included 3088 women with earlystage breast cancer Randomized to phone-based diet intervention or control WHEL Diet: High fruits and vegetables Low fat High fiber Pierce, Lancet 2007

26 Impact of Dietary Intervention on DFS Pierce et al., Lancet 2007.

27 Survival after WHEL Study enrollment by four diet and physical activity categories Pierce, J. P. et al. J Clin Oncol; 25: Copyright American Society of Clinical Oncology

28 Insulin and breast cancer prognosis N Hormone Results Goodwin 512 Insulin 2-fold risk of recurrence and 3-fold risk of death in highest vs. lowest quartile Irwin 608 C-peptide 3-fold risk of breast cancer death in top tertile vs. bottom tertile 3.5-fold risk of breast cancer death for women with type 2 diabetes vs. bottom tertile (low c-peptide and no diabetes) Goodwin et al. JCO 2001;20:42-51; Irwin ML, et al. Under review

29 Insulin and Breast Cancer Prognosis Hazard Rat p = p = Distant Recurrence Death > 51.9 Insulin Quartiles (pmol/l) Goodwin et al. JCO 2001;20:42-51

30 C-Peptide and Breast Cancer Death Hazard Ratio p = < > 2.5 T2D C-Peptide Tertiles (ng/ml) Breast Cancer Death Irwin ML, et al. Under Review

31 Sex Steroids Modification of sex steroid levels has long been a mainstay of cancer therapy Early treatment for breast cancer included removal of ovaries, adrenals, and other endocrine organs More recently, aromatase inhibitors, which lower estradiol levels to below detectable levels of most assays, have been shown to significantly improve prognosis and lower risk of second breast cancers

32 Estrogen Levels by BMI in 505 Postmenopausal Breast Cancer Patients pg/m P trend = Estrone Estradiol 5 P trend = < > 30 kg/m 2 McTiernan et al. J. Clin. Oncol. 2003;21:

33 Testosterone Levels by BMI in 505 Postmenopausal Breast Cancer Patient pg/m P trend = < > 30 Testosterone kg/m 2 McTiernan et al. J. Clin. Oncol. 2003;21:

34 Risk of Breast Cancer Death by Adiponectin (HEAL, 566 Stage I-IIIa patients, followed up mean 6 years) P=0.08 Hazard Rat Tertile 1 Tertile 2 Tertile 3 Adiponectin Duggan C, et al. To be submitted

35 2.5 2 Risk of Total Death by CRP (HEAL, 734 Stage 0-IIIa patients, followed up mean 6 years) P for trend=0.01 Hazard Rat <1.2 mg/l mg/l > 3.8 mg/l CRP tertiles Pierce, et al. JCO, In Press

36 Interventions to Increase Physical Activity levels in Cancer Survivors Growing number of exercise interventions conducted pre-surgery, during treatment, and post-treatment treatment Numerous benefits associated with exercise.

37 Future Research Directions Need more studies of lifestyle and survival in other cancers More exercise and weight loss trials with novel endpoints Common side effects of treatment Inflammation Cell proliferation Disease-free survival

38 Conclusions Increasing PA after diagnosis is associated with a decreased risk of breast cancer mortality and all cause mortality Especially among women who are inactive prior to diagnosis! More research is needed on how to maintain weight and increase physical activity after a cancer diagnosis.

39 HEAL Study Acknowledgements Rachel Ballard-Barbash Barbash,, NCI Anne McTiernan,, FHCRC Leslie Bernstein, COH Rick Baumgarter,, Louisville WHI Study Rowan Chlebowski,, UCLA Anne McTiernan,, FHCRC

Breast Cancer: Weight and Exercise. Anne McTiernan, MD, PhD. Fred Hutchinson Cancer Research Center Seattle, WA

Breast Cancer: Weight and Exercise. Anne McTiernan, MD, PhD. Fred Hutchinson Cancer Research Center Seattle, WA Breast Cancer: Weight and Exercise Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA Associations of Obesity with Overall & Breast Cancer Specific Survival Survival Obese vs. Non-obese

More information

Breast Cancer: Weight and Exercise. Anne McTiernan, MD, PhD. Fred Hutchinson Cancer Research Center Seattle, WA

Breast Cancer: Weight and Exercise. Anne McTiernan, MD, PhD. Fred Hutchinson Cancer Research Center Seattle, WA Breast Cancer: Weight and Exercise Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA Associations of Obesity with Overall & Breast Cancer Specific Survival Survival Obese vs. Non-obese

More information

Lifestyle Risk Factors and Cancer Prevention

Lifestyle Risk Factors and Cancer Prevention February 3-5, 2016 Lansdowne Resort, Leesburg, VA Lifestyle Risk Factors and Cancer Prevention Melinda L. Irwin, PhD, MPH Professor of Epidemiology, Yale School of Public Health, Associate Director (Population

More information

Physical Activity & Cancer What We Know, What We Don t Know. Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA

Physical Activity & Cancer What We Know, What We Don t Know. Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA Physical Activity & Cancer What We Know, What We Don t Know Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA What We Know Extensive epidemiologic research on relationship between

More information

Breast Cancer Survivorship

Breast Cancer Survivorship Breast Cancer Survivorship Melissa Accordino, MD Assistant Professor of Medicine Herbert Irving Comprehensive Cancer Center Columbia University Medical Center Who are the Cancer Survivors? More than 1

More information

Breast Cancer Survivorship: Physical Activity

Breast Cancer Survivorship: Physical Activity WORKING EVERYDAY TO PROVIDE THE HIGHEST QUALITY OF LIFE FOR PEOPLE WITH CANCER Breast Cancer Survivorship: What is the Role of Diet and Physical Activity WENDY DEMARK-WAHNEFRIED, PHD, RD PROFESSOR AND

More information

Low-Fat Dietary Pattern Intervention Trials for the Prevention of Breast and Other Cancers

Low-Fat Dietary Pattern Intervention Trials for the Prevention of Breast and Other Cancers Low-Fat Dietary Pattern Intervention Trials for the Prevention of Breast and Other Cancers Ross Prentice Fred Hutchinson Cancer Research Center and University of Washington AICR, November 5, 2009 Outline

More information

Physical activity, Obesity, Diet and Colorectal Cancer Prognosis. Jeffrey Meyerhardt, MD, MPH Dana-Farber Cancer Institute Boston, MA

Physical activity, Obesity, Diet and Colorectal Cancer Prognosis. Jeffrey Meyerhardt, MD, MPH Dana-Farber Cancer Institute Boston, MA Physical activity, Obesity, Diet and Colorectal Cancer Prognosis Jeffrey Meyerhardt, MD, MPH Dana-Farber Cancer Institute Boston, MA Colorectal Cancer Incidence ~148,000 cases in US annually and ~50,000

More information

Influence of Weight Management and Exercise on Other Outcomes

Influence of Weight Management and Exercise on Other Outcomes Influence of Weight Management and Exercise on Other Outcomes Melinda L. Irwin, PhD, MPH Professor of Epidemiology, Yale School of Public Health Associate Director for Population Sciences, Yale Cancer

More information

Journal of Clinical Oncology

Journal of Clinical Oncology Journal of Clinical Oncology Copy of e-mail Notification zlj7630 Your article (# 59822) from Journal of Clinical Oncology is available for download ===== Journal of Clinical Oncology Article no. 59822

More information

Physical Activity, Biomarkers, and Disease Outcomes in Cancer Survivors: A Systematic Review

Physical Activity, Biomarkers, and Disease Outcomes in Cancer Survivors: A Systematic Review JNCI Journal of the National Cancer Institute Advance Access published May 8, 2012 DOI: 10.1093/jnci/djs207 Published by Oxford University Press 2012. REVIEW Physical Activity, Biomarkers, and Disease

More information

Soyfood Consumption and Breast Cancer Survival. Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A.

Soyfood Consumption and Breast Cancer Survival. Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A. Soyfood Consumption and Breast Cancer Survival Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A. Objectives Brief summary of the health benefits of soyfood consumption

More information

Leveraging Prospective Cohort Studies to Advance Colorectal Cancer Prevention, Treatment and Biology

Leveraging Prospective Cohort Studies to Advance Colorectal Cancer Prevention, Treatment and Biology Leveraging Prospective Cohort Studies to Advance Colorectal Cancer Prevention, Treatment and Biology Charles S. Fuchs, MD, MPH Director, Yale Cancer Center Physician-in-Chief, Smilow Cancer Hospital New

More information

Soyfood Consumption and Breast Cancer Survival. Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A.

Soyfood Consumption and Breast Cancer Survival. Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A. Soyfood Consumption and Breast Cancer Survival Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A. Objectives Brief summary of the health benefits of soyfood consumption

More information

New Insights into Breast Cancer Risk Reduction

New Insights into Breast Cancer Risk Reduction New Insights into Breast Cancer Risk Reduction November 10, 2013 Rowan T. Chlebowski Professor of Medicine David Geffen School of Medicine at UCLA Chief, Division of Medical Oncology and Hematology Harbor-UCLA

More information

Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities Sao Jiralerspong and Pamela J. Goodwin

Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities Sao Jiralerspong and Pamela J. Goodwin VOLUME 34 NUMBER 35 DECEMBER 10, 2016 JOURNAL OF CLINICAL ONCOLOGY R E V I E W A R T I C L E Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities Sao Jiralerspong and Pamela J.

More information

Observational Studies vs. Randomized Controlled Trials

Observational Studies vs. Randomized Controlled Trials Observational Studies vs. Randomized Controlled Trials Edward Giovannucci, MD, ScD Harvard School of Public Health Harvard Medical School Boston MA 02115 (1)The relevance of observational data as compared

More information

Exercise as Medicine for Cancer Management. Robert U. Newton, PhD

Exercise as Medicine for Cancer Management. Robert U. Newton, PhD Exercise as Medicine for Cancer Management Robert U. Newton, PhD What is Anabolic Exercise? Repetitive movements performed against resistance Resistance limits number completed e.g. 10 reps per set (10RM)

More information

Anthropometry: What Can We Measure & What Does It Mean?

Anthropometry: What Can We Measure & What Does It Mean? Anthropometry: What Can We Measure & What Does It Mean? Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, Washington, U.S.A. I have no conflicts to disclose. Anthropometry in Human

More information

4/13/2010. Silverman, Buchanan Breast, 2003

4/13/2010. Silverman, Buchanan Breast, 2003 Tailoring Breast Cancer Treatment: Has Personalized Medicine Arrived? Judith Luce, M.D. San Francisco General Hospital Avon Comprehensive Breast Care Center Outline First, treatment of DCIS Sorting risk

More information

Optimal Nutritional Goals for the Cancer Survivor

Optimal Nutritional Goals for the Cancer Survivor W O R K I N G E V E R Y D A Y T O P R O V I D E T H E H I G H E S T Q U A L I T Y O F L I F E F O R P E O P L E W I T H C A N C E R Optimal Nutritional Goals for the Cancer Survivor W E N D Y D E M AR

More information

Eating and Exercising toward Better Health in Cancer Survivors

Eating and Exercising toward Better Health in Cancer Survivors W O R K I N G E V E R Y D A Y T O P R O V I D E T H E H I G H E S T Q U A L I T Y O F L I F E F O R P E O P L E W I T H C A N C E R Eating and Exercising toward Better Health in Cancer Survivors W E N

More information

Update from the 29th Annual San Antonio Breast Cancer Symposium

Update from the 29th Annual San Antonio Breast Cancer Symposium Update from the 29th Annual San Antonio Breast Cancer Symposium The San Antonio Breast Cancer Symposium is one of the most important breast cancer conferences. Approximately 8,000 physicians, oncologists,

More information

This paper is available online at

This paper is available online at Thomson CA, Van Horn L, Caan BJ, Aragaki AK, Chlebowski RT, Manson JE, Rohan TE, Tinker LF, Kuller LH, Hou L, Lane DS, Johnson KC, Vitolins M, Prentice R. This paper is available online at http://cebp.aacrjournals.org/cgi/content/abstract/1055-9965.epi-14-0922

More information

Survivorship: Lifestyle Modifications of Diet and Exercise

Survivorship: Lifestyle Modifications of Diet and Exercise Survivorship: Lifestyle Modifications of Diet and Exercise Alice S. Ryan, PhD Professor Division of Gerontology and Geriatric Medicine University of Maryland School of Medicine VA Senior Research Career

More information

Pamela J. Goodwin, M.D., M.Sc., F.R.C.P.C.

Pamela J. Goodwin, M.D., M.Sc., F.R.C.P.C. Overview of the Evidence Relating Cancer Outcomes to Obesity and Body Weight Pamela J. Goodwin, M.D., M.Sc., F.R.C.P.C. Professor of Medicine University of Toronto Obesity Trends* Among U.S. Adults BRFSS,

More information

Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL Study

Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL Study DOI 10.1007/s10552-010-9714-3 ORIGINAL PAPER Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL Study Lisa A. Cadmus Bertram

More information

Chapter 2 The Link Between Obesity and Breast Cancer Risk: Epidemiological Evidence

Chapter 2 The Link Between Obesity and Breast Cancer Risk: Epidemiological Evidence Chapter 2 The Link Between Obesity and Breast Cancer Risk: Epidemiological Evidence 2.1 BMI and Breast Cancer Risk BMI is routinely used to qualify an individual s adiposity, yet it is simply a measure

More information

Obesity and Breast Cancer Risk in Hispanics: Findings from the Breast Cancer Health Disparities Study

Obesity and Breast Cancer Risk in Hispanics: Findings from the Breast Cancer Health Disparities Study Obesity and Breast Cancer Risk in Hispanics: Findings from the Breast Cancer Health Disparities Study Esther M. John, PhD, MSPH Senior Research Scientist Cancer Prevention Institute of California AICR

More information

Survivorship and Breast Cancer in Older Patients

Survivorship and Breast Cancer in Older Patients Survivorship and Breast Cancer in Older Patients Michelle Melisko MD Clinical Professor of Medicine UCSF Helen Diller Family Comprehensive Cancer Center Disclosures Research support: Nektar, Novartis,

More information

Host Factors that Increase Breast Cancer Risk

Host Factors that Increase Breast Cancer Risk Host Factors that Increase Breast Cancer Risk 30 th Annual Miami Breast Cancer Conference March 7-10, 2013 Debu Tripathy, MD Professor of Medicine University of Southern California Norris Comprehensive

More information

Medical risk reducing strategies for breast cancer

Medical risk reducing strategies for breast cancer Medical risk reducing strategies for breast cancer PROF. DR. H. DEPYPERE Menopause Clinic, University Hospital, Ghent, Belgium Life expectancy in Belgium 46,6 y in 1880 and 83,8 y in 2014 2 Women Men Aantal

More information

HEALTH CARE DISPARITIES. Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center

HEALTH CARE DISPARITIES. Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center HEALTH CARE DISPARITIES Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center Goals Understand the epidemiology of breast cancer Understand the broad management of breast cancer

More information

Extended Hormonal Therapy

Extended Hormonal Therapy Extended Hormonal Therapy Dr. Caroline Lohrisch, Medical Oncologist, BC Cancer Agency Vancouver Centre November 1, 2014 www.fpon.ca Optimal Endocrine Therapy for Women with Hormone Receptor Positive Early

More information

No effect of exercise on insulin-like growth factor (IGF)-1, insulin and glucose in young women participating in a 16-week randomized controlled trial

No effect of exercise on insulin-like growth factor (IGF)-1, insulin and glucose in young women participating in a 16-week randomized controlled trial University of North Florida UNF Digital Commons Nutrition and Dietetics Faculty Publications Department of Nutrition and Dietetics 11-2010 No effect of exercise on insulin-like growth factor (IGF)-1, insulin

More information

Obesity and Cancer Survivorship. Cynthia Thomson, PhD, RD Professor-Mel & Enid Zuckerman College of Public Health University of Arizona

Obesity and Cancer Survivorship. Cynthia Thomson, PhD, RD Professor-Mel & Enid Zuckerman College of Public Health University of Arizona Obesity and Cancer Survivorship Cynthia Thomson, PhD, RD Professor-Mel & Enid Zuckerman College of Public Health University of Arizona Objectives Describe the relationship between obesity, weight gain

More information

Beyond Standard Therapy for Colorectal Cancer: Role of Energy Balance in Treatment of Survivors

Beyond Standard Therapy for Colorectal Cancer: Role of Energy Balance in Treatment of Survivors Beyond Standard Therapy for Colorectal Cancer: Role of Energy Balance in Treatment of Survivors Jeffrey Meyerhardt, MD, MPH Dana-Farber Cancer Institute Boston, MA 1 Disclosure Ad Board: Genentech Honorarium:

More information

Cancer Survivors: - Asian Perspective

Cancer Survivors: - Asian Perspective Cancer Survivors: What we Know, What we Need to Know - Asian Perspective Prof. Josette Sin-yee Chor School of Public Health and Primary Care The Chinese University of Hong Kong Asia Varying incidence of

More information

What is new in HR+ Breast Cancer? Olivia Pagani Breast Unit and Institute of oncology of Southern Switzerland

What is new in HR+ Breast Cancer? Olivia Pagani Breast Unit and Institute of oncology of Southern Switzerland What is new in HR+ Breast Cancer? Olivia Pagani Breast Unit and Institute of oncology of Southern Switzerland Outline Early breast cancer Advanced breast cancer Open questions Outline Early breast cancer

More information

Symposium 6 Part ll BAPEN M d e i di l ca /N l/n t u irti ition S i oc t e y Nutritional Science i n in C ancer Cancer

Symposium 6 Part ll BAPEN M d e i di l ca /N l/n t u irti ition S i oc t e y Nutritional Science i n in C ancer Cancer Symposium 6 Part ll BAPEN Medical/Nutrition iti Society Nutritional Science in Cancer Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective Professor Martin Wiseman FRCP

More information

SOFTly: The Long Natural History of [Trials for] [premenopausal] ER+ Breast Cancer

SOFTly: The Long Natural History of [Trials for] [premenopausal] ER+ Breast Cancer SOFTly: The Long Natural History of [Trials for] [premenopausal] ER+ Breast Cancer Charles Moertel Lecture May 12, 2017 Gini Fleming Charles Moertel Founder of NCCTG Dedication to high quality clinical

More information

Evidence for the Role of Obesity in Breast Cancer Progression

Evidence for the Role of Obesity in Breast Cancer Progression Evidence for the Role of Obesity in Breast Cancer Progression Pamela J. Goodwin, M.D., M.Sc., F.R.C.P.C. Professor of Medicine Mount Sinai and Princess Margaret Hospitals University of Toronto BMI and

More information

The Role of Observational Studies. Edward Giovannucci, MD, ScD Departments of Nutrition and Epidemiology

The Role of Observational Studies. Edward Giovannucci, MD, ScD Departments of Nutrition and Epidemiology The Role of Observational Studies Edward Giovannucci, MD, ScD Departments of Nutrition and Epidemiology Disclosure Information As required, I would like to report that I have no financial relationships

More information

Issues in Cancer Survivorship. Larissa A. Korde, MD, MPH June 26, 2010

Issues in Cancer Survivorship. Larissa A. Korde, MD, MPH June 26, 2010 Issues in Cancer Survivorship Larissa A. Korde, MD, MPH June 26, 2010 Estimated US Cancer Cases in Women: 2006-2008 CA Cancer J Clin 2006; 56:106-130; CA Cancer J Clin 2008;58:71 96. Relative Survival*

More information

Seigo Nakamura,M.D.,Ph.D.

Seigo Nakamura,M.D.,Ph.D. Seigo Nakamura,M.D.,Ph.D. Professor of Surgery Director of Breast Center Showa University Hospital Chairman of the board of directors Japan Breast Cancer Society Inhibition of Estrogen-Dependent Growth

More information

Early Stage Disease. Hope S. Rugo, MD Professor of Medicine Director Breast Oncology and Clinical Trials Education UCSF Comprehensive Cancer Center

Early Stage Disease. Hope S. Rugo, MD Professor of Medicine Director Breast Oncology and Clinical Trials Education UCSF Comprehensive Cancer Center SABCS 2014: Early Stage Disease Hope S. Rugo, MD Professor of Medicine Director Breast Oncology and Clinical Trials Education UCSF Comprehensive Cancer Center Topics for Discussion Chemotherapy plus 10

More information

Increased Risk of Breast Cancer: Screening and Prevention. Elizabeth Pritchard, MD 4/5/2017

Increased Risk of Breast Cancer: Screening and Prevention. Elizabeth Pritchard, MD 4/5/2017 Increased Risk of Breast Cancer: Screening and Prevention Elizabeth Pritchard, MD 4/5/2017 No disclosures Defining Risk Risk Factors Modifiable Lifestyle obesity physical activity alcohol consumption breast

More information

8/8/2011. PONDERing the Need to TAILOR Adjuvant Chemotherapy in ER+ Node Positive Breast Cancer. Overview

8/8/2011. PONDERing the Need to TAILOR Adjuvant Chemotherapy in ER+ Node Positive Breast Cancer. Overview Overview PONDERing the Need to TAILOR Adjuvant in ER+ Node Positive Breast Cancer Jennifer K. Litton, M.D. Assistant Professor The University of Texas M. D. Anderson Cancer Center Using multigene assay

More information

Surgical treatment of BRCA mutated patients. Viviana Galimberti MD European Institute of Oncology Milan, Italy

Surgical treatment of BRCA mutated patients. Viviana Galimberti MD European Institute of Oncology Milan, Italy Surgical treatment of BRCA mutated patients Viviana Galimberti MD European Institute of Oncology Milan, Italy No pharmaceutical company funding was used I declare I have no conflicts of interest as regards

More information

Nutrition and gastrointestinal cancer: An update of the epidemiological evidence

Nutrition and gastrointestinal cancer: An update of the epidemiological evidence Nutrition and gastrointestinal cancer: An update of the epidemiological evidence Krasimira Aleksandrova, PhD MPH Nutrition, Immunity and Metabolsim Start-up Lab Department of Epidemiology German Institute

More information

부인암생존자의건강관리 - 암생존자의식이와운동요법

부인암생존자의건강관리 - 암생존자의식이와운동요법 제 32 차대한부인종양학회춘계학술대회 부인암생존자의건강관리 - 암생존자의식이와운동요법 Mi-Kyung Kim, MD, PhD Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cheil General Hospital & Women s Healthcare Center Dankook

More information

What is survivorship? Late effects of treatment. Concerns of survivorship

What is survivorship? Late effects of treatment. Concerns of survivorship Choices to enhance vitality!!!and survival!!!!!!!!! (and how to make it work in the real world)! What is survivorship? Multiple definitions! Anyone living with cancer at any stage since diagnosis! Anyone

More information

Emerging Approaches for (Neo)Adjuvant Therapy for ER+ Breast Cancer

Emerging Approaches for (Neo)Adjuvant Therapy for ER+ Breast Cancer Emerging Approaches for (Neo)Adjuvant Therapy for E+ Breast Cancer Cynthia X. Ma, M.D., Ph.D. Associate Professor of Medicine Washington University in St. Louis Outline Current status of adjuvant endocrine

More information

BSO, HRT, and ERT. No relevant financial disclosures

BSO, HRT, and ERT. No relevant financial disclosures BSO, HRT, and ERT Jubilee Brown, MD Professor & Associate Director, Gynecologic Oncology Levine Cancer Institute at the Carolinas HealthCare System Charlotte, North Carolina No relevant financial disclosures

More information

Use of Ovarian Suppression and Ablation in Breast Cancer Treatment

Use of Ovarian Suppression and Ablation in Breast Cancer Treatment Use of Ovarian Suppression and Ablation in Breast Cancer Treatment Dr Marina Parton Consultant Medical Oncologist Royal Marsden and Kingston Hospitals Overview Breast cancer phenotypes Use of ovarian manipulation

More information

Objectives. Survivors. Survivorship in Cancer 7/20/2018. Over 15 million survivors in the U.S. Over 32 million worldwide. Oncology Survivorship Care

Objectives. Survivors. Survivorship in Cancer 7/20/2018. Over 15 million survivors in the U.S. Over 32 million worldwide. Oncology Survivorship Care Survivorship in Cancer Oncology Survivorship Care Kathleen Martin, FNP-BC, AOCNP Objectives Define population of survivors of cancer Define the need for survivorship care Explain the purpose of survivorship

More information

BREAST CANCER AND BONE HEALTH

BREAST CANCER AND BONE HEALTH BREAST CANCER AND BONE HEALTH Rowena Ridout, MD, FRCPC Toronto Western Hospital Osteoporosis Program University Health Network / Mount Sinai Hospital rowena.ridout@uhn.ca None to declare Conflicts of Interest

More information

Analysing research on cancer prevention and survival. Diet, nutrition, physical activity and breast cancer survivors. In partnership with

Analysing research on cancer prevention and survival. Diet, nutrition, physical activity and breast cancer survivors. In partnership with Analysing research on cancer prevention and survival Diet, nutrition, physical activity and breast cancer survivors 2014 In partnership with Contents About World Cancer Research Fund International 1 Our

More information

Comparative effectiveness of strategies to prevent weight gain among women with and at risk for breast cancer: a systematic review

Comparative effectiveness of strategies to prevent weight gain among women with and at risk for breast cancer: a systematic review Chaudhry et al. SpringerPlus 2013, 2:277 a SpringerOpen Journal SHORT REPORT Open Access Comparative effectiveness of strategies to prevent weight gain among women with and at risk for breast cancer: a

More information

Obesity and Breast Cancer in a Multiethnic Population. Gertraud Maskarinec, MD, PhD University of Hawaii Cancer Center, Honolulu, HI

Obesity and Breast Cancer in a Multiethnic Population. Gertraud Maskarinec, MD, PhD University of Hawaii Cancer Center, Honolulu, HI Obesity and Breast Cancer in a Multiethnic Population Gertraud Maskarinec, MD, PhD University of Hawaii Cancer Center, Honolulu, HI Background Breast cancer incidence remains lower in many Asian than Western

More information

Adjuvant Endocrine Therapy: How Long is Long Enough?

Adjuvant Endocrine Therapy: How Long is Long Enough? Adjuvant Endocrine Therapy: How Long is Long Enough? Harold J. Burstein, MD, PhD Dana-Farber Cancer Institute Harvard Medical School Boston, Massachusetts hburstein@partners.org I have no conflicts to

More information

The Breast Cancer Weight Loss (BWEL) Trial

The Breast Cancer Weight Loss (BWEL) Trial Plenary Session: Integrative Innovations in Digital Health Technologies with Cancer Patients and Survivors The Breast Cancer Weight Loss (BWEL) Trial Jennifer Ligibel, MD Dana-Farber Cancer Institute SIO

More information

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance) JNCI J Natl Cancer Inst (2015) 107(9): djv179 doi:10.1093/jnci/djv179 First published online June 25, 2015 Article Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741

More information

Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva

Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer

More information

Alcohol & Cancer: from prevention to the patient

Alcohol & Cancer: from prevention to the patient Alcohol & Cancer: from prevention to the patient -from consistency to inconsistencies- Ellen Kampman Wageningen University Academic Medical Centre St Radboud Nijmegen 23 september 2010 Alcohol and the

More information

Breast Cancer and Bone Loss. One in seven women will develop breast cancer during a lifetime

Breast Cancer and Bone Loss. One in seven women will develop breast cancer during a lifetime Breast Cancer and Bone Loss One in seven women will develop breast cancer during a lifetime Causes of Bone Loss in Breast Cancer Patients Aromatase inhibitors Bil Oophorectomy Hypogonadism Steroids Chemotherapy

More information

Identifying and Meeting the Medical and Psychological Needs of Cancer Survivors Ann H. Partridge, MD, MPH

Identifying and Meeting the Medical and Psychological Needs of Cancer Survivors Ann H. Partridge, MD, MPH Identifying and Meeting the Medical and Psychological Needs of Cancer Survivors Ann H. Partridge, MD, MPH 2017 Master Class Course Presenter Disclosure Information The following relationships exist related

More information

38 years old, premenopausal, had L+snbx. Pathology: IDC Gr.II T-1.9cm N+2/4sn ER+100%st, PR+60%st, Her2-neg, KI %

38 years old, premenopausal, had L+snbx. Pathology: IDC Gr.II T-1.9cm N+2/4sn ER+100%st, PR+60%st, Her2-neg, KI % 38 years old, premenopausal, had L+snbx Pathology: IDC Gr.II T-1.9cm N+2/4sn ER+100%st, PR+60%st, Her2-neg, KI67 5-10% Question: What will you do now? 1. Give adjuvant chemotherapy 2. Send for Oncotype

More information

2/16/2017. Welcome to the COPE Webinar Series for Health Professionals! MacDonald Center for Obesity Prevention and Education (COPE) Goals

2/16/2017. Welcome to the COPE Webinar Series for Health Professionals! MacDonald Center for Obesity Prevention and Education (COPE) Goals Welcome to the COPE Webinar Series for Health Professionals! February 22, 2017 12 Noon-1 PM EST Diet Modification as a Novel Therapeutic for Cancer Treatment: When Less is More Moderator: Lisa Diewald,

More information

2/16/2017. CE Credits. CE Credits. Diet Modification as a Novel Therapeutic in Cancer Treatment: When Less is More

2/16/2017. CE Credits. CE Credits. Diet Modification as a Novel Therapeutic in Cancer Treatment: When Less is More Welcome to the COPE Webinar Series for Health Professionals! MacDonald Center for Obesity Prevention and Education (COPE) Goals February 22, 2017 12 Noon-1 PM EST Diet Modification as a Novel Therapeutic

More information

Breast Cancer The PRECAMA Study. Dr. Isabelle Romieu Head, Section of Nutrition and Metabolism

Breast Cancer The PRECAMA Study. Dr. Isabelle Romieu Head, Section of Nutrition and Metabolism Breast Cancer The PRECAMA Study Dr. Isabelle Romieu Head, Section of Nutrition and Metabolism Estimated incidence of breast cancer (2008) Age- standardised rates per 100,000 GLOBOCAN 2008 (globocan.iarc.fr)

More information

Current Strategies in the Detection of Breast Cancer. Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF

Current Strategies in the Detection of Breast Cancer. Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF Current Strategies in the Detection of Breast Cancer Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF Outline ν Screening Film Mammography ν Film ν Digital ν Screening

More information

Diet and Cancer: Prevention, Treatment and Survival

Diet and Cancer: Prevention, Treatment and Survival Diet and Cancer: Prevention, Treatment and Survival Tracy Crane, MS, RD Research Specialist, Sr. The University of Arizona Cancer Center and College of Public Health Educational Series Disclosure All Faculty,

More information

William J. Gradishar MD

William J. Gradishar MD Northwestern University Feinberg School of Medicine Adjuvant Endocrine Therapy For Postmenopausal Women SOBO 2013 William J. Gradishar MD Betsy Bramsen Professor of Breast Oncology Director, Maggie Daley

More information

The Latest Research: Hormonal Therapies

The Latest Research: Hormonal Therapies The Latest Research: Hormonal Therapies Sameer Gupta, M.D., M.P.H 9/29/2018 Attending Physician, Hematology/Oncology Bryn Mawr Hospital Clinical Assistant Professor, Jefferson Medical College Disclosures

More information

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention 6 Week Course Agenda Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention Lee-may Chen, MD Director, Division of Gynecologic Oncology Professor Department of Obstetrics, Gynecology

More information

Hormone therapy in Breast Cancer patients with comorbidities

Hormone therapy in Breast Cancer patients with comorbidities Hormone therapy in Breast Cancer patients with comorbidities Diana Crivellari Centro di Riferimento Oncologico Aviano- ITALY Madrid November 9th, 2007 Main issues Comorbidities in elderly women Hormonal

More information

Obesity and Cancer Survivorship: Where are we in Providing Care? Cynthia Thomson, PhD, RD Mary Koithan, PhD, RN, CNS-BC

Obesity and Cancer Survivorship: Where are we in Providing Care? Cynthia Thomson, PhD, RD Mary Koithan, PhD, RN, CNS-BC Obesity and Cancer Survivorship: Where are we in Providing Care? Cynthia Thomson, PhD, RD Mary Koithan, PhD, RN, CNS-BC Objectives This webinar will help you: Describe the relationship between obesity,

More information

Obesity and Breast Cancer Risk

Obesity and Breast Cancer Risk Program on Breast Cancer Environmental Risk Factors Fact Sheet #56 August 2007 TOPICS Measurement of obesity BMI and breast cancer risk Weight gain and loss and breast cancer risk Body fat distribution

More information

ORMONOTERAPIA ADIUVANTE: QUALE LA DURATA OTTIMALE? MARIANTONIETTA COLOZZA

ORMONOTERAPIA ADIUVANTE: QUALE LA DURATA OTTIMALE? MARIANTONIETTA COLOZZA ORMONOTERAPIA ADIUVANTE: QUALE LA DURATA OTTIMALE? MARIANTONIETTA COLOZZA THE NATURAL HISTORY OF HORMONE RECEPTOR- POSITIVE BREAST CANCER IS VERY LONG Recurrence hazard rate 0.3 0.2 0.1 0 ER+ (n=2,257)

More information

Manejo do câncer de mama RH+ na adjuvância: o que há de novo?

Manejo do câncer de mama RH+ na adjuvância: o que há de novo? II Simpósio Internacional de Câncer de Mama para o Oncologista Clínico Manejo do câncer de mama RH+ na adjuvância: o que há de novo? INGRID A. MAYER, MD, MSCI Assistant Professor of Medicine Director,

More information

Breast SSG Education Event Anglia Cancer Network Sally Donaghey Macmillan AHP Lead

Breast SSG Education Event Anglia Cancer Network Sally Donaghey Macmillan AHP Lead Breast SSG Education Event Anglia Cancer Network 10.2.2012 Sally Donaghey Macmillan AHP Lead sally.donaghey@suffolk.pct.nhs.uk IPx People affected by cancer need information that is timely, relevant, and

More information

Diet what helps? Lindsey Allan Macmillan Oncology Dietitian Royal Surrey County Hospital, Guildford

Diet what helps? Lindsey Allan Macmillan Oncology Dietitian Royal Surrey County Hospital, Guildford Diet what helps? Lindsey Allan Macmillan Oncology Dietitian Royal Surrey County Hospital, Guildford Diet and cancer Diet and cancer Nutrition research Lack of funding RCTs Low quality Small sample sizes

More information

SAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:

SAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN: Patient: Age: 40 Sex: F MRN: SAMPLE PATIENT Order Number: Completed: Received: Collected: SAMPLE REPORT Progesterone ng/ml 0.34 0.95 21.00 DHEA-S mcg/dl Testosterone ng/ml 48 35 0.10 0.54 0.80 430 Sex

More information

Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective 1 3

Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective 1 3 REVIEW Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer and Survival: A Global Perspective 1 3 Elisa V Bandera, 4,5 * Gertraud Maskarinec, 6 Isabelle Romieu, 7 and Esther M John

More information

Diabetes Mellitus and Breast Cancer

Diabetes Mellitus and Breast Cancer Masur K, Thévenod F, Zänker KS (eds): Diabetes and Cancer. Epidemiological Evidence and Molecular Links. Front Diabetes. Basel, Karger, 2008, vol 19, pp 97 113 Diabetes Mellitus and Breast Cancer Ido Wolf

More information

Connecting Links for Reducing Risks: Understanding the impact of obesity on cancer development. Kristi Acker, DNP, FNP-BC, AOCNP, ACHPN

Connecting Links for Reducing Risks: Understanding the impact of obesity on cancer development. Kristi Acker, DNP, FNP-BC, AOCNP, ACHPN Connecting Links for Reducing Risks: Understanding the impact of obesity on cancer development Kristi Acker, DNP, FNP-BC, AOCNP, ACHPN Objectives 1) Identify factors that contribute to the financial burden

More information

The Center for Cancer Prevention and Treatment Public Reporting of Outcomes

The Center for Cancer Prevention and Treatment Public Reporting of Outcomes The Center for Cancer Prevention and Treatment 2017 Public Reporting of Outcomes Cancer Screening Program - CoC Standard 4.2 Oral Cancer Screening Event Identified Community Need According to the 2014

More information

Nutrition and Cancer Prevention. Elisa V. Bandera, MD, PhD

Nutrition and Cancer Prevention. Elisa V. Bandera, MD, PhD Nutrition and Cancer Prevention Elisa V. Bandera, MD, PhD The Causes of Cancer in the US. Sedentary lifestyle 5% Other 12% Family history 5 % Occupation 5% Tobacco 30% Reproductive factors 3% Pollution

More information

Integrative Medicine at SCCA: A New Program for Survivors

Integrative Medicine at SCCA: A New Program for Survivors Integrative Medicine at SCCA: A New Program for Survivors Heather Greenlee, ND, PhD Medical Director, Integrative Medicine Program Associate Member, Fred Hutch Associate Professor, UW School of Medicine

More information

Survivors of breast and other cancers

Survivors of breast and other cancers Survivors of breast and other cancers 2018 Contents World Cancer Research Fund Network 3 Introduction 5 1. Prevalence 6 2. Diet, nutrition, physical activity and cancer survival 8 2.1 Nature of the evidence

More information

The Neoadjuvant Model as a Translational Tool for Drug and Biomarker Development in Breast Cancer

The Neoadjuvant Model as a Translational Tool for Drug and Biomarker Development in Breast Cancer The Neoadjuvant Model as a Translational Tool for Drug and Biomarker Development in Breast Cancer Laura Spring, MD Breast Medical Oncology Massachusetts General Hospital Primary Mentor: Dr. Aditya Bardia

More information

Endocrine Therapy in Premenopausal Breast Cancer. Joyce O Shaughnessy, MD Baylor Sammons Cancer Center Texas Oncology, PA US Oncology

Endocrine Therapy in Premenopausal Breast Cancer. Joyce O Shaughnessy, MD Baylor Sammons Cancer Center Texas Oncology, PA US Oncology Endocrine Therapy in Premenopausal Breast Cancer Joyce O Shaughnessy, MD Baylor Sammons Cancer Center Texas Oncology, PA US Oncology Ovarian Ablation or Suppression vs. Not in ER + or ER UK Breast Cancer

More information

Can Diet Modulate Inflammation and Reduce Cancer Risk and Improve Survival? Evidence from the WHI

Can Diet Modulate Inflammation and Reduce Cancer Risk and Improve Survival? Evidence from the WHI Can Diet Modulate Inflammation and Reduce Cancer Risk and Improve Survival? Evidence from the WHI Fred Tabung, MSPH, PhD Departments of Nutrition and Epidemiology Harvard T. H. Chan School of Public Health

More information

Supplementary Table 1. Association of rs with risk of obesity among participants in NHS and HPFS

Supplementary Table 1. Association of rs with risk of obesity among participants in NHS and HPFS Supplementary Table 1. Association of rs3826795 with risk of obesity among participants in NHS and HPFS Case/control NHS (1990) HPFS (1996) OR (95% CI) P- value Case/control OR (95% CI) P- value Obesity

More information

Padma Tadi-Uppala, Ph.D. Loma Linda University, School of Public Health, CA August 10, 2010

Padma Tadi-Uppala, Ph.D. Loma Linda University, School of Public Health, CA August 10, 2010 Padma Tadi-Uppala, Ph.D. Loma Linda University, School of Public Health, CA August 10, 2010 Provide information about lifestyle factors such as diet, exercise and stress management that can prevent breast

More information

Exercise is Medicine for Cancer Management

Exercise is Medicine for Cancer Management 18/8/211 for Cancer Management Presented by: Robert Newton, PhD, Perth, Australia the human genome evolved over at least the last 5, years within an environment of high physical activity the current human

More information

Adjuvant Systemic Therapy in Early Stage Breast Cancer

Adjuvant Systemic Therapy in Early Stage Breast Cancer Adjuvant Systemic Therapy in Early Stage Breast Cancer Julie R. Gralow, M.D. Director, Breast Medical Oncology Jill Bennett Endowed Professor of Breast Cancer Professor, Global Health University of Washington

More information

International Graduate Course in Exercise & Clinical Physiology

International Graduate Course in Exercise & Clinical Physiology International Graduate Course in Exercise & Clinical Physiology Exercise and Cancer A view to the future through the eyes of the past Robert D. Kilgour, Ph.D., FACSM Professor & Chair Department of Exercise

More information

Hormone therapyduration: Can weselectthosepatientswho benefitfromtreatmentextension?

Hormone therapyduration: Can weselectthosepatientswho benefitfromtreatmentextension? Hormone therapyduration: Can weselectthosepatientswho benefitfromtreatmentextension? Ivana Sestak, PhD Centre for Cancer Prevention Wolfson Institute of Preventive Medicine Queen Mary University London

More information